DiaMedica Therapeutics Inc.

DMACNASDAQHealthcare● Active

$5.61

$-0.03(-0.53%)

Market Cap$302285313

P/E Ratio—

52W High$10.4195

52W Low$3.475

Avg Volume191K

Open$5.68

Beta1.00

Cash on Hand Financials Revenue

DiaMedica Therapeutics Inc. (DMAC) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

DMAC · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$59.9M▲ +35.7% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$15.6M

cashAndCashEquivalents

Short-Term Investments

$44.2M

shortTermInvestments

YoY Change vs Prior Year

+35.7%

vs prior fiscal year

Latest Quarter

$51.3M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$59.9MCash on Hand

Total Debt$240,000Total Debt

Net Cash / Net Debt+$59.6MNet Cash Position

Cash vs Debt Ratio

Cash 100%DiaMedica Therapeutics Inc. cash as % of market cap: 19.81%% · MCap $0BDebt 0%

DiaMedica Therapeutics Inc. has a net cash position of $59.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$59.9M − $240,000 = +$59.6M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

DMAC annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DMAC cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$59.9M+35.7%

Dec 31, 2024FY$44.1M-16.5%

Dec 31, 2023FY$52.9M+57.9%

Dec 31, 2022FY$33.5M-25.7%

Dec 31, 2021FY$45.1M+64.0%

DMAC cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

DMAC vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

DiaMedica Therapeutics Inc.YOU

DMAC

$59.9M$302M19.8%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

DiaMedica Therapeutics Inc. (DMAC) cash on hand as of December 31, 2025 is $59.9M, comprising $15.6M in cash and cash equivalents (CCE) plus $44.2M in short-term investments — reported as DiaMedica Therapeutics Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as DiaMedica Therapeutics Inc. cash reserves or cash position.

DiaMedica Therapeutics Inc. annual cash on hand history shows increased +35.7% in 2025: increased +35.7% in 2025. DiaMedica Therapeutics Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

DiaMedica Therapeutics Inc. carries total debt of $240,000 against cash of $59.9M, resulting in a net cash position of +$59.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

DMAC cash on hand · 5 questions

As of December 31, 2025, DiaMedica Therapeutics Inc. (DMAC) has $59,890,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $15,647,000 in cash and cash equivalents (CCE) plus $44,243,000 in short-term investments. Latest quarter (March 31, 2026): $51,331,000. Data sourced from the annual 10-K filing via FMP.

DMAC cash on handDMAC cash reservesDMAC cash 2025how much cash does DMAC have

▸ Source: FMP /balance-sheet-statement · US GAAP · DiaMedica Therapeutics Inc. · DiaMedica Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025